Table of contents:
Video: Multi-pill Could Reduce Cardiovascular Events
2023 Author: Lynn Laird | [email protected]. Last modified: 2023-05-21 21:10
According to the results of a recently published study, a multi-pill with a varied composition may reduce the risk of cardiovascular events in middle-aged people. But is it really possible and since when have these scientific discoveries existed? Decryption in the following paragraphs!
Multi-pill could reduce cardiovascular events
Also called polypill or superillule, this universal drug has in fact been around for twenty years. However, the new study, which was published in the medical journal The Lancet, is the first to be carried out on a large scale and to test the effectiveness of the multi-pill. Let's see what it is exactly.
The multi-pill represents a combination of aspirin and blood pressure and cholesterol medications, with the ability to reduce the risk of cardiovascular events by 34%. The study was carried out on approximately 7,000 people, representatives of the rural Turkmen population of Iran, with no history of cardiovascular disease in their families.
For information, the drug tested contains low doses of two pills for hypertension and a moderate dose of a component intended to fight against cholesterol, as well as aspirin, of course. If the multi-pill is adopted globally and at an affordable price, the UN will achieve its goal of reducing premature mortality from cardiovascular disease.